Choosing inhaler devices for people with asthma: Current knowledge and outstanding research needs

Respiratory Medicine

Volumn 104, Issue 9, 2010, Pages 1237-1245

  Haughney, John ^a   Price, David ^a   Barnes, Neil C ^b   Virchow, J Christian ^c   Roche, Nicolas ^d   Chrystyn, Henry ^e  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b LONDON CHEST HOSPITAL   (United Kingdom)

^c UNIVERSITY OF ROSTOCK   (Germany)

^d HÔTEL DIEU   (France)

^e UNIVERSITY OF HUDDERSFIELD   (United Kingdom)

Author keywords

Asthma control; Inhaler device; Inhaler technique; Primary care; Tool

Indexed keywords

BECLOMETASONE; CHLOROFLUOROCARBON; CORTICOSTEROID; HYDROFLOUROALKANE; PROPELLANT; UNCLASSIFIED DRUG;

ASTHMA; DRUG DELIVERY SYSTEM; HUMAN; INHALER; METERED DOSE INHALER; PARTICLE SIZE; POWDER INHALER; PRIORITY JOURNAL; REVIEW;

ANTI-ASTHMATIC AGENTS; ASTHMA; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; NEBULIZERS AND VAPORIZERS; NEEDS ASSESSMENT; PARTICLE SIZE; PATIENT SELECTION;

EID: 77955654081     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2010.04.012     Document Type: Review

References (60)

1. British Thoracic Society, Scottish Intercollegiate Guidelines Network British guideline on the management of asthma May 2008 http://www.sign.ac.uk/ guidelines/fulltext/101/index.html revised June 2009
2. Global Initiative for Asthma (GINA) Global strategy for asthma management and prevention 2009 http://www.ginasthma.org [Updated 2009]
3. P. Sestini, V. Cappiello, and M. Aliani et al. Prescription bias and factors associated with improper use of inhalers J Aerosol Med 19 2006 127 136
4. J. Haughney, D. Price, and A. Kaplan et al. Achieving asthma control in practice: understanding the reasons for poor control Respir Med 102 2008 1681 1693
5. R. Horne, D. Price, and J. Cleland et al. Can asthma control be improved by understanding the patient's perspective? BMC Pulm Med 7 2007 8
6. D. Brocklebank, F. Ram, and J. Wright et al. Comparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: a systematic review of the literature Health Technol Assess 5 2001 1 149
7. D. Brocklebank, J. Wright, and C. Cates Systematic review of clinical effectiveness of pressurised metered dose inhalers versus other hand held inhaler devices for delivering corticosteroids in asthma BMJ 323 2001 896 900 (Pubitemid 32980478)
8. M.B. Dolovich, R.C. Ahrens, and D.R. Hess et al. Device selection and outcomes of aerosol therapy: Evidence-based guidelines: American College of Chest Physicians/American College of Asthma, Allergy, and Immunology Chest 127 2005 335 371
9. M.G. Cochrane, M.V. Bala, K.E. Downs, J. Mauskopf, and R.H. Ben-Joseph Inhaled corticosteroids for asthma therapy: patient compliance, devices, and inhalation technique Chest 117 2000 542 550
10. F. Lavorini, A. Magnan, and J.C. Dubus et al. Effect of incorrect use of dry powder inhalers on management of patients with asthma and COPD Respir Med 102 2008 593 604
11. M. Molimard, C. Raherison, S. Lignot, F. Depont, A. Abouelfath, and N. Moore Assessment of handling of inhaler devices in real life: An observational study in 3811 patients in primary care J Aerosol Med 16 2003 249 254
12. J. Lenney, J.A. Innes, and G.K. Crompton Inappropriate inhaler use: assessment of use and patient preference of seven inhalation devices. EDICI Respir Med 94 2000 496 500
13. M. Schulte, K. Osseiran, and R. Betz et al. Handling of and preferences for available dry powder inhaler systems by patients with asthma and COPD J Aerosol Med Pulm Drug Deliv 21 2008 321 328
14. A. Hardwell, V. Barber, T. Hargadon, and M. Levy Technique training does not improve the ability of most patients to use pressurised Metered Dose Inhalers (pMDI) Prim Care Respir J 18 2009 A1 Abstract
15. S.P. Newman, A.W. Weisz, N. Talaee, and S.W. Clarke Improvement of drug delivery with a breath actuated pressurised aerosol for patients with poor inhaler technique Thorax 46 1991 712 716
16. A. Lahdensuo, and A. Muittari Bronchodilator effects of a fenoterol metered dose inhaler and fenoterol powder in asthmatics with poor inhaler technique Eur J Respir Dis 68 1986 332 335
17. S. Lindgren, B. Bake, and S. Larsson Clinical consequences of inadequate inhalation technique in asthma therapy Eur J Respir Dis 70 1987 93 98
18. V. Giraud, and N. Roche Misuse of corticosteroid metered-dose inhaler is associated with decreased asthma stability Eur Respir J 19 2002 246 251
19. B.Y. Khassawneh, M.K. Al-Ali, and K.H. Alzoubi et al. Handling of inhaler devices in actual pulmonary practice: metered-dose inhaler versus dry powder inhalers Respir Care 53 2008 324 328
20. J. van der Palen, J.J. Klein, C.L. van Herwaarden, G.A. Zielhuis, and E.R. Seydel Multiple inhalers confuse asthma patients Eur Respir J 14 1999 1034 1037
21. M. Thomas, D. Price, H. Chrystyn, A. Lloyd, A.E. Williams, and J. von Ziegenweidt Inhaled corticosteroids for asthma: impact of practice level device switching on asthma control BMC Pulm Med 9 2009 1
22. Kemp L, Barnes N, Haughney J, Sims E, von Ziegenweidt J, Price D. The effectiveness of different inhaler types used in the "real-life" management of asthma (GPRD-REALITY). AAAAI Annual Meeting; 2009 13-17 March; Washington DC. Abstract.
23. L. Kemp, D. Price, E. Sims, P. Dorinsky, and J. von Ziegenweidt 'Real-Life' Effectiveness of Qvar, Beclomethasone and Fluticasone J Allergy Clin Immunol 123 2009 6 Abstract
24. D. Price, M. Thomas, G. Mitchell, C. Niziol, and R. Featherstone Improvement of asthma control with a breath-actuated pressurised metred dose inhaler (BAI): a prescribing claims study of 5556 patients using a traditional pressurised metred dose inhaler (MDI) or a breath-actuated device Respir Med 97 2003 12 19
25. C.L. Leach, P.J. Davidson, B.E. Hasselquist, and R.J. Boudreau Lung deposition of hydrofluoroalkane-134a beclomethasone is greater than that of chlorofluorocarbon fluticasone and chlorofluorocarbon beclomethasone: a cross-over study in healthy volunteers Chest 122 2002 510 516
26. J.R. Carstairs, A.J. Nimmo, and P.J. Barnes Autoradiographic visualization of beta-adrenoceptor subtypes in human lung Am Rev Respir Dis 132 1985 541 547
27. J.C. Mak, and P.J. Barnes Autoradiographic visualization of muscarinic receptor subtypes in human and guinea pig lung Am Rev Respir Dis 141 1990 1559 1568
28. P.K. Jeffery Structural, immunologic, and neural elements of the normal human airway wall W. Busse, S.T. Holgate, editors. Asthma and rhinitis 1995 Blackwell Scientific Publications Oxford 80 106
29. Q. Hamid, Y. Song, and T.C. Kotsimbos et al. Inflammation of small airways in asthma J Allergy Clin Immunol 100 1997 44 51
30. M.K. Tulic, and Q. Hamid New insights into the pathophysiology of the small airways in asthma Clin Chest Med 27 2006 41 52
31. H. Chrystyn Anatomy and physiology in delivery: can we define our targets? Allergy 54 Suppl. 49 1999 82 87
32. O.S. Usmani, M.F. Biddiscombe, and P.J. Barnes Regional lung deposition and bronchodilator response as a function of beta2-agonist particle size Am J Respir Crit Care Med 172 2005 1497 1504
33. R.A. Al-Showair, S.B. Pearson, and H. Chrystyn The potential of a 2Tone Trainer to help patients use their metered-dose inhalers Chest 131 2007 1776 1782
34. E.F. Juniper, D.B. Price, P.A. Stampone, J.P. Creemers, S.J. Mol, and P. Fireman Clinically important improvements in asthma-specific quality of life, but no difference in conventional clinical indexes in patients changed from conventional beclomethasone dipropionate to approximately half the dose of extrafine beclomethasone dipropionate Chest 121 2002 1824 1832
35. R.J. Martin Exploring the distal lung: new direction in asthma Isr Med Assoc J 10 2008 846 849
36. C.L. Leach, P.J. Davidson, and R.J. Boudreau Improved airway targeting with the CFC-free HFA-beclomethasone metered-dose inhaler compared with CFC-beclomethasone Eur Respir J 12 1998 1346 1353
37. W.W. Busse, S. Brazinsky, and K. Jacobson et al. Efficacy response of inhaled beclomethasone dipropionate in asthma is proportional to dose and is improved by formulation with a new propellant J Allergy Clin Immunol 104 1999 1215 1222
38. T.H. Self, N.A. Pinner, R.S. Sowell, and A.S. Headley Does it really matter what volume to exhale before using asthma inhalation devices? J Asthma 46 2009 212 216
39. S.P. Newman, D. Pavia, N. Garland, and S.W. Clarke Effects of various inhalation modes on the deposition of radioactive pressurized aerosols Eur J Respir Dis Suppl 119 1982 57 65
40. R. Pauwels, S. Newman, and L. Borgstrom Airway deposition and airway effects of antiasthma drugs delivered from metered-dose inhalers Eur Respir J 10 1997 2127 2138
41. H.S. Tomlinson, S.A. Corlett, M.B. Allen, and H. Chrystyn Assessment of different methods of inhalation from salbutamol metered dose inhalers by urinary drug excretion and methacholine challenge Br J Clin Pharmacol 60 2005 605 610
42. A.E. Hesselink, B.W. Penninx, H.A. Wijnhoven, D.M. Kriegsman, and J.T. van Eijk Determinants of an incorrect inhalation technique in patients with asthma or COPD Scand J Prim Health Care 19 2001 255 260
43. C.J. Nimmo, D.N. Chen, S.M. Martinusen, T.L. Ustad, and D.N. Ostrow Assessment of patient acceptance and inhalation technique of a pressurized aerosol inhaler and two breath-actuated devices Ann Pharmacother 27 1993 922 927
44. A.R. Clark, and A.M. Hollingworth The relationship between powder inhaler resistance and peak inspiratory conditions in healthy volunteers-implications for in vitro testing J Aerosol Med 6 1993 99 110
45. H. Chrystyn, and D. Price What you need to know about inhalers and how to use them Prescriber 20 12 2009 47 52
46. M.E. Broeders, J. Molema, N.A. Vermue, and H.T. Folgering Peak inspiratory flow rate and slope of the inhalation profiles in dry powder inhalers Eur Respir J 18 2001 780 783
47. T. Weuthen, S. Roeder, P. Brand, B. Mullinger, and G. Scheuch In vitro testing of two formoterol dry powder inhalers at different flow rates J Aerosol Med 15 2002 297 303
48. A. Palander, T. Mattila, M. Karhu, and E. Muttonen In vitro comparison of three salbutamol-containing multidose dry powder inhalers: Buventol Easyhaler(R), Inspiryl Turbuhaler(R) and Ventoline Diskus(R) Clin Drug Investig 20 2000 25 33
49. L. Borgstrom, E. Bondesson, F. Moren, E. Trofast, and S.P. Newman Lung deposition of budesonide inhaled via Turbuhaler: a comparison with terbutaline sulphate in normal subjects Eur Respir J 7 1994 69 73
50. S.P. Newman, F. Morén, E. Trofast, N. Talaee, and S.W. Clarke Terbutaline sulphate Turbuhaler: effect of inhaled flow rate on drug deposition and efficacy Int J Pharm 74 1991 209 213
51. H. Bisgaard, B. Klug, B.S. Sumby, and P.K. Burnell Fine particle mass from the Diskus inhaler and Turbuhaler inhaler in children with asthma Eur Respir J 11 1998 1111 1115
52. M.E. Broeders, J. Molema, P.K. Burnell, and H.T. Folgering Ventolin Diskus and Inspyril Turbuhaler: an in vitro comparison J Aerosol Med 18 2005 74 82
53. W.Y. Tarsin, S.B. Pearson, K.H. Assi, and H. Chrystyn Emitted dose estimates from Seretide Diskus and Symbicort Turbuhaler following inhalation by severe asthmatics Int J Pharm 316 2006 131 137
54. S.A. Diamond, and K.R. Chapman The impact of a nationally coordinated pharmacy-based asthma education intervention Can Respir J 8 2001 261 265
55. S.L. Janson, K.W. McGrath, J.K. Covington, S.C. Cheng, and H.A. Boushey Individualized asthma self-management improves medication adherence and markers of asthma control J Allergy Clin Immunol 123 2009 840 846
56. I.A. Basheti, C.L. Armour, S.Z. Bosnic-Anticevich, and H.K. Reddel Evaluation of a novel educational strategy, including inhaler-based reminder labels, to improve asthma inhaler technique Patient Educ Couns 72 2008 26 33
57. S.P. Newman, N. Talaee, and S.W. Clarke Salbutamol aerosol delivery in man with the Rondo-Spacer Acta Ther 17 1991 49 50
58. S.H. Mazhar, and H. Chrystyn Salbutamol relative lung and systemic bioavailability of large and small spacers J Pharm Pharmacol 60 2008 1609 1613
59. E. Ronmark, R. Jogi, and A. Lindqvist et al. Correct use of three powder inhalers: comparison between Diskus, Turbuhaler, and Easyhaler J Asthma 42 2005 173 178
60. H. Chrystyn Is inhalation rate important for a dry powder inhaler? Using the In-Check Dial to identify these rates Respir Med 97 2003 181 187